Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for InterCure Ltd. (INCR : NSDQ)
 
 • Company Description   
InterCure is a cannabis company. It is a licensed cannabis producer which offer good manufacturing practices certified and pharmaceutical-grade medical cannabis products. InterCure is based in NEW YORK.

Number of Employees: 350

 
 • Price / Volume Information   
Yesterday's Closing Price: $7.23 Daily Weekly Monthly
20 Day Moving Average: 110,409 shares
Shares Outstanding: 42.74 (millions)
Market Capitalization: $308.97 (millions)
Beta:
52 Week High: $8.77
52 Week Low: $4.50
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 17.94% 32.83%
12 Week 15.86% 27.37%
Year To Date 11.57% 37.08%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
85 MEDINAT HA-YEHUDIM STREET
-
HERZLIYA,L3 4676670
ISR
ph: 972-77-460-5012
fax: -
None http://www.intercure.co
 
 • General Corporate Information   
Officers
Alexander Rabinovich - Chief Executive Officer
Ehud Barak - Chairman
Amos Cohen - Chief Financial Officer
David Salton - Director
Alon Granot - Director

Peer Information
- (-)
- (-)
- (-)
- (-)
- (-)
- (-)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: M549GJ111
SIC: 2834
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 09/07/22
Share - Related Items
Shares Outstanding: 42.74
Most Recent Split Date: (:1)
Beta:
Market Capitalization: $308.97 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 09/07/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: 60.25
PEG Ratio: -
Price Ratios
Price/Book: 2.17
Price/Cash Flow: 82.61
Price / Sales: 3.61
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: 650.00%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: 8.05%
ROE
03/31/22 - 3.30
12/31/21 - -
09/30/21 - -
ROA
03/31/22 - 2.31
12/31/21 - -
09/30/21 - -
Current Ratio
03/31/22 - -
12/31/21 - 1.74
09/30/21 - 1.90
Quick Ratio
03/31/22 - -
12/31/21 - 1.39
09/30/21 - 1.58
Operating Margin
03/31/22 - 5.38
12/31/21 - -
09/30/21 - -
Net Margin
03/31/22 - 5.38
12/31/21 - -
09/30/21 - -
Pre-Tax Margin
03/31/22 - -
12/31/21 - 8.28
09/30/21 - -
Book Value
03/31/22 - -
12/31/21 - 3.33
09/30/21 - 3.26
Inventory Turnover
03/31/22 - -
12/31/21 - 2.49
09/30/21 - -
Debt-to-Equity
03/31/22 - -
12/31/21 - 0.07
09/30/21 - 0.05
Debt-to-Capital
03/31/22 - -
12/31/21 - 6.77
09/30/21 - 5.16
 

Powered by Zacks Investment Research ©